Monday, October 31, 2016 1:44:46 PM
My take:
Meaning: We are still a long ways off, not days or weeks, but months or years to get where we want and need to be to conduct clinical trials.
Meaning: We are continuing our F&F share plan, so don't be surprised when next financials show more money raised with .02-.05 shares being issued to company insiders. We are still a long ways away from being able to sign a contract with a pharmaceutical company for licensing or underwriting our research, but one day we hope to get there. Meanwhile they are asking for a lot more data and proof of concept before they are willing to sign on the dotted line.
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM